{{Rsnum
|rsid=7164176
|Chromosome=15
|position=91668544
|Orientation=plus
|GMAF=0.3145
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 34.5 | 46.9 | 18.6
| HCB | 56.9 | 37.2 | 5.8
| JPT | 59.3 | 32.7 | 8.0
| YRI | 81.6 | 17.0 | 1.4
| ASW | 64.9 | 29.8 | 5.3
| CHB | 56.9 | 37.2 | 5.8
| CHD | 63.3 | 33.9 | 2.8
| GIH | 26.7 | 57.4 | 15.8
| LWK | 89.1 | 10.9 | 0.0
| MEX | 53.4 | 36.2 | 10.3
| MKK | 75.0 | 23.1 | 1.9
| TSI | 36.3 | 41.2 | 22.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=5E-7
|OR=0.2800
|ORtxt=None
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}